Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.

These results suggest that implementation of paromomycin-miltefosine combination therapy indeed could represent a safe and affordable treatment option for L. donovani VL as miltefosine appears to overrule the anticipated rapid development of PMM resistance.